Catalyst
Slingshot members are tracking this event:
Lexicon (LXRX) Expects Initial Phase 1 Data in 2017 for LX2761 in Diabetes
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| LXRX |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 09, 2017
Occurred Source:
http://www.lexpharma.com/media-center/news/619-lexicon-begins-phase-1-clinical-trial-of-locally-acting-sglt1-inhibitor-lx2761-for-potential-treatment-of-diabetes
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 1, Lx2761, Diabetes, Initial Data
